| Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs M He, H Qin, TCW Poon, SC Sze, X Ding, NN Co, SM Ngai, TF Chan, ... Carcinogenesis 36 (9), 1008-1018, 2015 | 275 | 2015 |
| microRNA and cancer M Li, J Li, X Ding, M He, SY Cheng The AAPS journal 12, 309-317, 2010 | 217 | 2010 |
| Genomic and epigenomic features of primary and recurrent hepatocellular carcinomas X Ding, M He, AWH Chan, QX Song, SC Sze, H Chen, MKH Man, K Man, ... Gastroenterology 157 (6), 1630-1645. e6, 2019 | 167 | 2019 |
| Over‐expression of AEG‐1 significantly associates with tumour aggressiveness and poor prognosis in human non‐small cell lung cancer L Song, W Li, H Zhang, W Liao, T Dai, C Yu, X Ding, L Zhang, J Li The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 156 | 2009 |
| Long‐read RNA sequencing identifies alternative splice variants in hepatocellular carcinoma and tumor‐specific isoforms H Chen, F Gao, M He, XF Ding, AM Wong, SC Sze, AC Yu, T Sun, ... Hepatology 70 (3), 1011-1025, 2019 | 67 | 2019 |
| An RFC4/Notch1 signaling feedback loop promotes NSCLC metastasis and stemness L Liu, T Tao, S Liu, X Yang, X Chen, J Liang, R Hong, W Wang, Y Yang, ... Nature Communications 12 (1), 2693, 2021 | 58 | 2021 |
| Patient-derived tumor organoid predicts drugs response in glioblastoma: A step forward in personalized cancer therapy? HHF Loong, AM Wong, DTM Chan, MSH Cheung, C Chow, X Ding, ... Journal of Clinical Neuroscience 78, 400-402, 2020 | 42 | 2020 |
| AluScan: a method for genome-wide scanning of sequence and structure variations in the human genome L Mei, X Ding, SY Tsang, FW Pun, SK Ng, J Yang, C Zhao, D Li, W Wan, ... BMC genomics 12, 1-9, 2011 | 28 | 2011 |
| Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates X Ding, L Jiang, C Ke, Z Yang, C Lei, K Cao, J Xu, L Xu, X Yang, Y Zhang, ... Virus Genes 41, 329-340, 2010 | 24 | 2010 |
| Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response Y Kumar, J Yang, T Hu, L Chen, Z Xu, L Xu, XX Hu, G Tang, JM Wang, ... BMC medical genomics 8, 1-21, 2015 | 22 | 2015 |
| NN Co, SM Ngai, TF Chan, N. Wong, Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs M He, H Qin, TC Poon, SC Sze, X Ding Carcinogenesis 36 (9), 1008-1018, 2015 | 20 | 2015 |
| Application of machine learning to development of copy number variation-based prediction of cancer risk X Ding, SY Tsang, SK Ng, H Xue Genomics insights 7, GEI. S15002, 2014 | 20 | 2014 |
| Unique molecular characteristics of NAFLD-associated liver cancer accentuate β-catenin/TNFRSF19-mediated immune evasion AM Wong, X Ding, AM Wong, M Xu, L Zhang, HHW Leung, AWH Chan, ... Journal of Hepatology 77 (2), 410-423, 2022 | 19 | 2022 |
| Improving the calling of non-invasive prenatal testing on 13-/18-/21-trisomy by support vector machine discrimination J Yang, X Ding, W Zhu PLoS One 13 (12), e0207840, 2018 | 19 | 2018 |
| SAMSVM: a tool for misalignment filtration of SAM-format sequences with support vector machine J Yang, X Ding, X Sun, SY Tsang, H Xue Journal of bioinformatics and computational biology 13 (06), 1550025, 2015 | 18 | 2015 |
| Copy number variation analysis based on AluScan sequences JF Yang, XF Ding, L Chen, WK Mat, MZ Xu, JF Chen, JM Wang, L Xu, ... Journal of Clinical Bioinformatics 4, 1-14, 2014 | 18 | 2014 |
| TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk YK Lam, J Yu, H Huang, X Ding, AM Wong, HH Leung, AW Chan, KK Ng, ... Hepatology 78 (3), 727-740, 2023 | 17 | 2023 |
| Forward and reverse mutations in stages of cancer development T Hu, Y Kumar, I Shazia, SJ Duan, Y Li, L Chen, JF Chen, R Yin, A Kwong, ... Human genomics 12, 1-21, 2018 | 13 | 2018 |
| m6A‐Dependent Modulation via IGF2BP3/MCM5/Notch Axis Promotes Partial EMT and LUAD Metastasis X Yang, Q Bai, W Chen, J Liang, F Wang, W Gu, L Liu, Q Li, Z Chen, ... Advanced Science 10 (20), 2206744, 2023 | 11 | 2023 |
| Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity M Xu, Y Liu, HL Wan, AM Wong, X Ding, W You, WS Lo, KKC Ng, N Wong Cancer letters 548, 215898, 2022 | 9 | 2022 |
